Management of Type 1 Supracondylar Humeral Fractures
Management of Type 1 Supracondylar Humeral Fractures: a Multicentre Randomized Control Trial
University of British Columbia
52 participants
Apr 1, 2021
INTERVENTIONAL
Conditions
Summary
This study compares the clinical outcomes of treating pediatric Type 1 supracondylar fracture with a long arm soft cast and no clinical or radiographic follow-up versus the standard treatment in a long arm cast with clinical follow-up. This is the first multicenter randomized control trial looking at the clinical effectiveness, safety and parental satisfaction of managing inherently stable Type I supracondylar fractures without clinical or radiological follow-up. If found to be safe; children can be managed effectively without in-person follow-up, freeing clinic appointments to children on the waiting list and in these COVID times avoiding unnecessary contacts.
Eligibility
Inclusion Criteria1
- \- Children 3 to 8 years of age with a diagnosed supracondylar humerus fracture Type 1 (undisplaced).
Exclusion Criteria5
- Children diagnosed with a Type II or III supracondylar fracture or any other elbow injury
- Children who present with neurovascular compromise associated with their fracture
- Children who have been previously diagnosed with a metabolic or structural bone disease that predisposes them to fractures
- Diagnostic criteria for a Type I supracondylar fracture will include either:
- A) A clear fracture line through the supracondylar region with no displacement or angulation of the distal humerus (including a normal anterior humeral line that intersects the capitellum) OR B) The absence of a clear fracture line but history of an extension injury to the arm AND tenderness at the elbow AND local swelling AND presence of a posterior fat pad on plain radiographs.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants in group 2 will have a long arm soft cast applied without clinical or radiological follow up.
Participants in group 1 will have a long arm full cast applied.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04642807